Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Bumble (BMBL) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Bumble and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.

image for news BUMBLE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors to Contact the Firm Regarding the Investigation into Bumble, Inc.

Coupang: Don't Be Too Early To Book Gains — Positive

CPNG   Seeking Alpha — October 07, 2025

Coupang, Inc. has finally turned the corner on profitability, but after years of lackluster stock performance, the market is still failing to properly price its next chapter of growth. The company is successfully replicating its dominant, logistics-first playbook in Taiwan, a market with ideal characteristics for hyper-growth, and early results already paint a promising picture. A simple valuation exercise reveals the market is ascribing a low value to the company's developing offerings segment, creating a clear valuation disconnect.

image for news Coupang: Don't Be Too Early To Book Gains

Lexeo: Maintaining Buy Rating Based On FDA Accelerated Approval Feedback — Positive

LXEO   Seeking Alpha — October 07, 2025

Lexeo Therapeutics received positive FDA feedback, enabling a faster path to Accelerated Approval for LX2006 in FA cardiomyopathy. Pooled phase 1/2 interim data for LX2006 show LVMI improvements well above FDA thresholds at 6 and 12 months, supporting efficacy. LXEO maintains strong financials, with cash reserves expected to fund operations into 2028 after a recent $80 million private placement.

image for news Lexeo: Maintaining Buy Rating Based On FDA Accelerated Approval Feedback

Affirm: Profitable Growth Story Gaining Speed — Positive

AFRM   Seeking Alpha — October 07, 2025

Affirm Holdings is rated a Buy with a $97 price target, reflecting 29% upside potential driven by strong BNPL market growth. AFRM delivered robust FQ4 2025 results, including 33% revenue growth, improved profitability, and a 43% increase in gross merchandise volume. Despite trading at a premium valuation, AFRM's exceptional revenue and cash flow growth justify its higher multiples compared to peers.

image for news Affirm: Profitable Growth Story Gaining Speed

RADNOR, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH) on behalf of those who purchased or otherwise acquired Lantheus securities between February 26, 2025, and August 5, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is November 10, 2025.

image for news Lantheus Holdings, Inc. (LNTH) Investors: November 10, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

AMD: Solid Gains, But The Market May Still Be Underreacting — Neutral

AMD   Seeking Alpha — October 07, 2025

Advanced Micro Devices remains a cautious buy after a 30% rally, driven by a major deal with OpenAI and strong AI market positioning. OpenAI's endorsement diversifies its supplier base beyond Nvidia, aligns financial interests, and signals AMD's technology is competitive in AI inference. Risks include potential dilution, execution challenges, and the circular nature of AI industry investments, though current demand supports sustainability.

image for news AMD: Solid Gains, But The Market May Still Be Underreacting

Archer-Daniels-Midland Company remains a reliable Dividend King, but current valuation and industry headwinds justify maintaining a Hold rating. Recent developments include pressure on commodity prices, lower EPS, strategic partnerships, and ongoing macro risks such as China halting US soybean purchases. ADM faces risks from potential US agricultural policy shifts, over-subsidization of corn, and management's apparent focus on short-term performance over long-term investment.

image for news Archer-Daniels-Midland: U.S. Biofuel Policy Change And China's Soybean Ban Could Bring An Opportunity

Former FDA vaccine chief Peter Marks joins Eli Lilly, STAT reports — Positive

LLY   Reuters — October 07, 2025

Peter Marks, the former top vaccine regulator at the U.S. Food and Drug Administration, has joined Eli Lilly , STAT News reported on Tuesday.

image for news Former FDA vaccine chief Peter Marks joins Eli Lilly, STAT reports

HIVE Digital Technologies (HIVE) Surges 25.2%: Is This an Indication of Further Gains? — Positive

HIVE   Zacks Investment Research — October 07, 2025

HIVE Digital Technologies (HIVE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

image for news HIVE Digital Technologies (HIVE) Surges 25.2%: Is This an Indication of Further Gains?

Newly announced trims still hover closer to $40,000 than $30,000 — a price that many investors view as putting the vehicle within mass-market reach.

image for news Tesla just unveiled a cheaper Model Y and Model 3. Why the stock is falling.

NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PubMatic, Inc. (NASDAQ: PUBM) between February 27, 2025 and August 11, 2025, both dates inclusive (the “Class Period”), of the important October 20, 2025 lead plaintiff deadline.

image for news PUBM DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages PubMatic, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PUBM

VIEW Reactions to Tesla's launch of cheaper Model Y and Model 3 — Positive

TSLA   Reuters — October 07, 2025

Tesla unveiled more affordable versions of its best-selling Model Y SUV and its Model 3 sedan on Tuesday at $39,990 and $36,990, respectively, as the electric-vehicle maker seeks to reverse falling sales and waning market share amid rising competition.

image for news VIEW Reactions to Tesla's launch of cheaper Model Y and Model 3

DraftKings and FanDuel-parent Flutter have seen their stocks fall more than 20% over the last month, as prediction markets threaten to win their gambling customers.

image for news DraftKings and FanDuel Extend Losing Streak as Prediction Markets Gain Steam

DB2RE Announces Sale of 46,000-SF Industrial Property Leased to Nucor Rebar — Neutral

NUE   Business Wire — October 07, 2025

DALLAS--(BUSINESS WIRE)--Davidson Bogel Real Estate (“DB2RE”) is pleased to announce the investment sale of 4700 Singleton Boulevard in Dallas, Texas. The property totals 46,000 square feet of warehouse space. It features substantial outside storage, fully leased to Nucor Rebar, a division of Nucor Corporation (NYSE: NUE) — one of the nation's largest and most respected steel manufacturers. Positioned in the West Dallas infill corridor, the property offers immediate access to Interstate 30, Loo.

image for news DB2RE Announces Sale of 46,000-SF Industrial Property Leased to Nucor Rebar

Top Performing Leveraged/Inverse ETFs: 10/05/2025 — Neutral

BITU  BITX  CONL  ETHT  ETHU  MSOX  MSTX  SMCX   ETF Trends — October 07, 2025

Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

image for news Top Performing Leveraged/Inverse ETFs: 10/05/2025

497,099. That's how many vehicles Tesla delivered through its third quarter, a record quarterly total. Of these, about 97% were Model 3 and Model Y vehicles.

image for news Tesla Unveils Cheaper Model Y And Model 3—Countering Tax Credit Loss

Tesla Debuts Cheaper, Stripped-Down Version of Model Y — Neutral

TSLA   WSJ — October 07, 2025

The discount on a more affordable electric vehicle doesn't make up for the lost EV tax credit that U.S. consumers used to get

image for news Tesla Debuts Cheaper, Stripped-Down Version of Model Y

NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the “Class Period”), of the important November 18, 2025 lead plaintiff deadline.

image for news ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – JSPR

Hands-on STEM projects, technology and equipment to build stronger, enabled communities HENDERSON, Nev. , Oct. 7, 2025 /PRNewswire/ -- Equipping students and teachers with the right tools and resources goes a long way in preparing for the STEM jobs of today and tomorrow.

image for news Toyota Drives Student Success with $5.8 Million to Support Nevada Students, Teachers

SAN DIEGO , Oct. 7, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that the C3.ai class action lawsuit – captioned Liggett v. C3.ai, Inc., No.

image for news C3.AI INVESTOR NOTICE: C3.ai, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit